Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

VEGFR2/CD309 anticorps

Cet anticorps anti-VEGFR2/CD309 Monoclonal Rat (Clone DC101) (ABIN6938746) détecte spécifiquement VEGFR2/CD309 dans WB. L’anticorps est réactif avec des échantillons de Souris.
N° du produit ABIN6938746
639,45 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 6 à 10 jours ouvrables

Aperçu rapide pour VEGFR2/CD309 anticorps (ABIN6938746)

Antigène

Voir toutes VEGFR2/CD309 (VEGFR2) Anticorps
VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

Reactivité

  • 339
  • 216
  • 140
  • 17
  • 9
  • 5
  • 4
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Souris

Hôte

  • 298
  • 67
  • 41
  • 14
  • 1
  • 1
Rat

Clonalité

  • 276
  • 146
Monoclonal

Conjugué

  • 182
  • 34
  • 20
  • 16
  • 14
  • 10
  • 10
  • 8
  • 8
  • 8
  • 8
  • 7
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp VEGFR2/CD309 est non-conjugé

Application

  • 223
  • 116
  • 115
  • 113
  • 65
  • 36
  • 26
  • 22
  • 20
  • 15
  • 13
  • 13
  • 9
  • 7
  • 7
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB)

Clone

DC101
  • Fonction

    VEGF-R2 / CD309 / Flk-1 / KDR3 Antibody

    Specificité

    This MAb is specific to Mouse VEGFR2/FLK-1/CD309 and does not cross-react with FLK-2. VEGFR2 is a type I transmembrane glycoprotein. It is a member of the CSF-1/PDGF receptor family of type III tyrosine kinase receptors. Endothelial cells, embryonic tissues, and megakaryocytes mainly express VEGFR2. It plays an important role in the regulation of angiogenesis, vasculogenesis, and vascular permeability. The ligands of VEGFR2 include VEGF-A, VEGF-C, VEGF-D, and VEGF splice isoforms. Ligation of VEGFR2 with its ligands results in the receptor dimerization and auto-phosphorylation, stimulating endothelial cell proliferation and migration.

    Purification

    200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G.

    Immunogène

    Recombinant full-length Mouse VEGFR2 protein

    Isotype

    IgG1, kappa
  • Indications d'application

    Positive Control: Mouse epidermoid, renal cell carcinoma, pancreatic or glioblastoma cells.

    Known Application: Western Blot (Non-reducing) (2-5 μg/mL), Blocks Binding of VEGF to VEGF-R2 (Order Ab without BSA & Azide), Inhibits VEGF-induced Signaling (Order Ab without BSA & Azide), Blocks Tumor Growth in mice (Order Ab without BSA & Azide), Neutralizing, Optimal dilution for a specific application should be determined.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10  mM PBS

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Date de péremption

    24 months
  • Antigène

    VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

    Autre désignation

    VEGFR2

    Sujet

    CD309, Fetal liver kinase 1 (FLK-1), KDR, Kinase insert domain receptor (a type III receptor tyrosine kinase), KRD1, Ly73, Protein tyrosine kinase receptor FLK1, Vascular endothelial growth factor receptor 2

    Mouse epidermoid, pancreatic or glioblastoma cells., renal cell carcinoma

    Poids moléculaire

    180-190kDa

    ID gène

    16542, 35918, 285

    Pathways

    Signalisation RTK, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Vous êtes ici:
Chat with us!